Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Blood|March 15, 1992
The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuriaM Ploug, T Plesner, E Rønne, et al.Journal of Internal Medicine|December 9, 2010
Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screeningA Kjellman, O Akre, O Gustafsson, et al.Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient miceA Jögi, J Pass, G Høyer-Hansen, et al.British Journal of Haematology|March 1, 1995
The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuriaE Rønne, H Pappot, J Grøndahl-Hansen, et al.European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Elevated plasma levels of urokinase plasminogen activator receptor in non-small cell lung cancer patientsH Pappot, G Høyer-Hansen, E Rønne, et al.European Journal of Biochemistry|April 15, 1992
Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activatorH Solberg, D Løber, J Eriksen, et al.Journal of Immunological Methods|January 3, 1994
Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assayE Rønne, N Behrendt, M Ploug, et al.Scandinavian Journal of Immunology|January 13, 2011
Soluble urokinase plasminogen activator receptor during allogeneic stem cell transplantationE Haastrup, J Andersen, S R Ostrowski, et al.The Journal of Biological Chemistry|September 5, 1992
Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domainG Høyer-Hansen, E Rønne, H Solberg, et al.Scandinavian Journal of Immunology|June 13, 2006
Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapyS R Ostrowski, T L Katzenstein, M Pedersen, et al.Pageof 7